Metabolism of tumors under treatment: Mapping of metabolites with quantitative bioluminescence

Radiotherapy and Oncology

Volumn 99, Issue 3, 2011, Pages 398-403

  Broggini Tenzer, Angela ^a   Vuong, Van ^a   Pruschy, Martin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Epothilone B; Glucose; Ionizing radiation; Lactate; Microtubule stabilizing agent; Tumor metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUFFER; EPOTHILONE B; GLUCOSE; LACTIC ACID; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER GROWTH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RESPONSE; EX VIVO STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; TISSUE SECTION; TUMOR CELL; TUMOR XENOGRAFT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPOTHILONES; GLYCOLYSIS; HUMANS; LACTIC ACID; LUCIFERASES; LUMINESCENT MEASUREMENTS; LUNG NEOPLASMS; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 79960376335     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.041     Document Type: Article

References (51)

1. R.E. Airley, and A. Mobasheri Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics Chemotherapy 53 2007 233 256 (Pubitemid 47074647)
2. N. Suzawa, M. Ito, and S. Qiao Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size Lung Cancer 72 2010 191 198
3. M. Tian, H. Zhang, Y. Nakasone, K. Mogi, and K. Endo Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study Eur J Nucl Med Mol Imaging 31 2004 5 12 (Pubitemid 38133535)
4. I. Freitas, V. Bertone, and P. Griffini In situ lactate dehydrogenase patterns as markers of tumour oxygenation Anticancer Res 11 1991 1293 1299
5. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 2004 891 899 (Pubitemid 39472955)
6. O. Feron Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells Radiother Oncol 92 2009 329 333
7. C.V. Dang, and G.L. Semenza Oncogenic alterations of metabolism Trends Biochem Sci 24 1999 68 72 (Pubitemid 29346576)
8. G. Kroemer, and J. Pouyssegur Tumor cell metabolism: cancer's Achilles' heel Cancer Cell 13 2008 472 482 (Pubitemid 351766797)
9. G.L. Semenza Tumor metabolism: cancer cells give and take lactate J Clin Invest 118 2008 3835 3837
10. O. Warburg On the origin of cancer cells Science 123 1956 309 314
11. D.M. Brizel, T. Schroeder, and R.L. Scher Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 349 353 (Pubitemid 32884281)
12. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis Semin Cancer Biol 19 2009 25 31
13. P. Vaupel Metabolic microenvironment of tumor cells: a key factor in malignant progression Exp Oncol 32 2011 125 127
14. S. Walenta, and W.F. Mueller-Klieser Lactate: mirror and motor of tumor malignancy Semin Radiat Oncol 14 2004 267 274 (Pubitemid 38903231)
15. S. Walenta, T. Schroeder, and W. Mueller-Klieser Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology Curr Med Chem 11 2004 2195 2204 (Pubitemid 38967739)
16. S. Walenta, M. Wetterling, and M. Lehrke High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers Cancer Res 60 2000 916 921 (Pubitemid 30129526)
17. J. Grotius, C. Dittfeld, M. Huether, W. Mueller-Klieser, M. Baumann, and L.A. Kunz-Schughart Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro Int J Radiat Biol 85 2009 989 1001
18. J. Overgaard Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis Radiother Oncol 2011 10.1016/j.radonc.2011.03.004
19. U.G. Sattler, S.S. Meyer, and V. Quennet Glycolytic metabolism and tumour response to fractionated irradiation Radiother Oncol 94 2009 102 109
20. V.K. Gupta, N.T. Jaskowiak, and M.A. Beckett Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance Cancer J 8 2002 47 54
21. C. Oehler, D.J. Dickinson, and A. Broggini-Tenzer Current concepts for the combined treatment modality of ionizing radiation with anticancer agents Curr Pharm Des 13 2007 519 535 (Pubitemid 46477755)
22. C. Rohrer Bley, K. Orlowski, P. Furmanova, P.M.J. McSheehy, and M. Pruschy Regulation of VEGF-expression by patupilone and ionizing radiation in lung adenocarcinoma cells Lung Cancer 2011 10.1016/j.lungcan.2011.01.010
23. J.M. Brown Tumor microenvironment and the response to anticancer therapy Cancer Biol Ther 1 2002 453 458
24. B.R. Pieters, D.Z. de Back, C.C. Koning, and A.H. Zwinderman Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review Radiother Oncol 93 2009 168 173
25. A. Yaromina, H. Thames, and X. Zhou Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation Radiother Oncol 96 2010 116 122
26. P. Morchel, G. Melkus, and A. Yaromina Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose Radiother Oncol 96 2010 123 130
27. M.H. Janssen, M.C. Ollers, and R.G. van Stiphout Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer Radiother Oncol 95 2010 203 208
28. E.G. Troost, P. Laverman, and J.H. Kaanders Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors Radiother Oncol 80 2006 157 164 (Pubitemid 44314018)
29. P. Vera, P. Bohn, and A. Edet-Sanson Simultaneous positron emission tomography (PET) assessment of metabolism with (1)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (1)F-fluoro-thymidine (FLT), and hypoxia with (1)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2010 109 116
30. V. Quennet, A. Yaromina, and D. Zips Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice Radiother Oncol 81 2006 130 135 (Pubitemid 44780779)
31. G. Schwickert, S. Walenta, K. Sundfor, E.K. Rofstad, and W. Mueller-Klieser Correlation of high lactate levels in human cervical cancer with incidence of metastasis Cancer Res 55 1995 4757 4759
32. S. Walenta, T.V. Chau, and T. Schroeder Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129 2003 321 326 (Pubitemid 36963193)
33. S. Walenta, A. Salameh, and H. Lyng Correlation of high lactate levels in head and neck tumors with incidence of metastasis Am J Pathol 150 1997 409 415 (Pubitemid 27073770)
34. C.R. Bley, W. Jochum, and K. Orlowski Role of the microenvironment for radiosensitization by patupilone Clin Cancer Res 15 2009 1335 1342
35. C. Oehler-Janne, W. Jochum, and O. Riesterer Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models Mol Cancer Ther 6 2007 2496 2504 (Pubitemid 47480415)
36. O. Riesterer, M. Honer, W. Jochum, C. Oehler, S. Ametamey, and M. Pruschy Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment Clin Cancer Res 12 2006 3518 3524
37. C. Hess, V. Vuong, and I. Hegyi Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth Br J Cancer 85 2001 2010 2016 (Pubitemid 34775341)
38. B. Hofstetter, V. Vuong, and A. Broggini-Tenzer Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo Clin Cancer Res 11 2005 1588 1596 (Pubitemid 40315244)
39. O. Riesterer, D. Zingg, J. Hummerjohann, S. Bodis, and M. Pruschy Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells Oncogene 23 2004 4624 4635 (Pubitemid 38850410)
40. K.H. Altmann Microtubule-stabilizing agents: a growing class of important anticancer drugs Curr Opin Chem Biol 5 2001 424 431
41. K.H. Altmann, M. Wartmann, and T. O'Reilly Epothilones and related structures-a new class of microtubule inhibitors with potent in vivo antitumor activity Biochim Biophys Acta 1470 2000 M79 91
42. K.N. Bhalla Microtubule-targeted anticancer agents and apoptosis Oncogene 22 2003 9075 9086 (Pubitemid 38121708)
43. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat Rev Cancer 4 2004 253 265 (Pubitemid 38525281)
44. K.A. Mason Radiation interactions with taxanes, old and new Radiat Res 163 2005 705 706
45. P. Specenier, and J.B. Vermorken The role of taxanes and targeted therapies in locally advanced head and neck cancer Curr Opin Oncol 19 2007 195 201 (Pubitemid 46597477)
46. C.P. Yang, P. Verdier-Pinard, and F. Wang A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence Mol Cancer Ther 4 2005 987 995 (Pubitemid 40909081)
47. W. Mueller-Klieser, and S. Walenta Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging Histochem J 25 1993 407 420 (Pubitemid 23181269)
48. M.H. Janssen, H.J. Aerts, and R.G. Kierkels Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings Radiother Oncol 94 2010 156 160
49. M.H. Janssen, M.C. Ollers, and R.G. van Stiphout Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings Radiother Oncol 94 2010 151 155
50. S. Bral, M. Duchateau, and M. De Ridder Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC Radiother Oncol 91 2009 438 442
51. M. Busk, M.R. Horsman, S. Jakobsen, and J. Bussink Van der Kogel, A, Overgaard, J. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage Eur J Nucl Med Mol Imaging 35 2008 2294 2303